Related Experiment Video
Updated: Jul 12, 2026

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
Published on: September 14, 2019
Methylprednisolone acetate immune suppression produces differing effects on Cryptosporidium muris oocyst production
Thomas A Miller1, Frank W Schaefer
1US Environmental Protection Agency, 26 West Martin Luther King Drive, Cincinnati, OH 45268, United States.
Abstract:
At different times after inoculation with Cryptosporidium muris, infected CF-1 female mice were immunosuppressed with a single subcutaneous dose of methylprednisolone acetate (MPA; 600 mg/kg). MPA immunosuppression decreases circulating CD3, CD4 and CD8 T-lymphocytes and B-lymphocytes by greater than 90% for approximately 14 days with numbers not returning to pre-suppression levels until after 41 days post-suppression. Immunosuppression was initiated at selected times before, during, and after oocyst production. Immunosuppression initiated prior to oocyst production delayed the start of production by 4-5 days and extended oocyst shedding by 16 days. Initiation of immunosuppression during oocyst production both extended oocyst shedding and greatly increased the number of oocysts shed per day over most of the extended shedding period. Immunosuppression during the decline of oocyst production resulted in only a moderate extension of shedding and a moderate increase in oocyst numbers. Immunosuppression initiated soon after oocyst shedding had ceased resulted in the re-initiation of limited oocyst production for only a few days. Suppression initiated on days 40 and 46 post-infection, 11 and 17 days after oocysts could no longer be detected in the feces, did not result in a resumption of oocyst production. In all cases, where oocyst production was extended or reinitiated, the shedding of oocysts halted between days 45 and 53 post-oocyst inoculation. These studies demonstrate that the effect of MPA immunosuppression depends on the immunologic conditions existing in the host at the time immunosuppression was initiated. Immunosuppression initiated during oocyst production allows an overwhelming parasitism to exist, implying that T- and B-lymphocytes play an important role in moving the host immune process along during this period of the infection. Conversely, severe suppression of T- and B-lymphocytes initiated as oocyst production is decreasing does not result in a complete relapse of the disease suggesting that T- and B-lymphocytes are not critical to the continuation of the immune process after this point. These studies also show that the C. muris infection persists beyond the end of the detection of oocysts in the feces.
Insights
Methylprednisolone acetate (MPA) immunosuppression impacts Cryptosporidium muris oocyst shedding based on timing. Early immunosuppression significantly extends shedding, while later suppression has minimal effects, highlighting lymphocyte roles in infection control.
Area of Science:
- Immunology
- Parasitology
- Infectious Diseases
Background:
- Cryptosporidium muris is an opportunistic protozoan parasite.
- The role of host immune responses, particularly T- and B-lymphocytes, in controlling C. muris infection is not fully understood.
- Methylprednisolone acetate (MPA) is a potent immunosuppressive drug.
Purpose of the Study:
- To investigate the impact of MPA-induced immunosuppression on the course of C. muris infection in mice.
- To determine how the timing of immunosuppression initiation affects oocyst shedding and parasite persistence.
- To elucidate the role of T- and B-lymphocytes in managing C. muris infection at different stages.
Main Methods:
- CF-1 female mice were inoculated with C. muris.
- Mice received a single dose of MPA (600 mg/kg) at various time points relative to oocyst production (before, during, after).
- Oocyst shedding, lymphocyte counts (CD3, CD4, CD8 T-lymphocytes, B-lymphocytes), and infection persistence were monitored.
Main Results:
- MPA immunosuppression significantly reduced T- and B-lymphocyte populations for over 14 days.
- Initiating immunosuppression before or during oocyst production delayed onset, extended shedding duration, and increased daily oocyst output.
- Immunosuppression during oocyst decline or after shedding ceased had minimal impact on oocyst production, though infection persisted.
- Oocyst shedding consistently halted between days 45 and 53 post-inoculation, regardless of immunosuppression timing.
Conclusions:
- The effect of MPA immunosuppression on C. muris infection is highly dependent on the host's immune status at the time of administration.
- T- and B-lymphocytes play a critical role in controlling C. muris during the active oocyst production phase.
- Suppression of lymphocytes later in the infection suggests they are less critical for maintaining immune control after oocyst shedding declines.
- C. muris infection persists in mice even after oocyst shedding becomes undetectable.
Related Concept Videos
Cryptococcal Meningitis
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

